1. Australian Government. Medicines Safety Update, Volume 8, Number 1, February 2017. Available at: https://www.tga.gov.au/publication-issue/medicines-safety-update-volume-8-number-1-february-2017#a2. [Accessed March 24, 2021]
2. The ABC's of dopamine receptor partial agonists - aripiprazole, brexpiprazole and cariprazine: the 15-min challenge to sort these agents out;Citrome;Int. J. Clin. Pract.,2015
3. Novel antipsychotics specificity profile: a clinically oriented review of lurasidone, brexpiprazole, cariprazine and lumateperone;Corponi;Eur. Neuropsychopharmacol.,2019
4. Risk of gambling disorder and impulse control disorder with aripiprazole, pramipexole, and ropinirole: a pharmacoepidemiologic study;Etminan;J. Clin. Psychopharmacol.,2017
5. European Medicines Agency (EMA). Guideline on the use of statistical signal detection methods in the Eudravigilance data analysis system. Available at: http://www.ema.europa.eu/docs/en_GB/document_library/Regulatory_and_procedural_guideline/2009/11/WC500011437.pdf. [Accessed April 1, 2021 ].